Zecotek Photonics (ZMSPF) 0.3181 $ZMSPF
Zecotek Granted Patent from Japanese Patent Office for its 3D Display Technology
CNW Group - Wed Jul 08, 8:57AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Japanese Patent Office has issued a patent to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 and U.S. patent number 9,055,288 granted in June 2015 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.400 (-0.005)
Zecotek Provides Corporate Update on 3D Technology Division
CNW Group - Mon Jul 06, 5:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge 3D display and 3D printing technologies. The Company was founded with a vision to grow shareholder value by commercializing photonic technologies that offer both superior performance and economic advantages over competing technologies. Zecotek`s internationally patented 3D auto-stereoscopic, full high definition display monitor and patent pending 3D metal printer provide substantial business opportunities for the robust and inevitable future markets based on 3D technologies.
ZMS.VN: 0.400 (-0.005)
CERN Tests Show Zecotek's Patented LFS Scintillation Crystals Achieve Superior Coincident Timing Resolution for New High Performance PET Scanners
CNW Group - Tue Jun 16, 7:45AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I;OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Company's patented LFS scintillation crystals achieved a more precise coincident time resolution (CTR) when compared to competing crystals in tests conducted by a CERN research group, on crystals with dimensions used in commercial positron emission tomography (PET) medical scanners. The results were presented at a recent 2015 IEEE Nuclear Science Conference in Seattle and have been published in major journals.(i)
ZMS.VN: 0.400 (-0.005)
Zecotek Granted U.S. Patent for Switchable 3D/2D Optical Imaging System
PR Newswire - Mon Jun 01, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has granted U.S. Patent No. 9,055,288 to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.400 (-0.005)
Zecotek Provides Corporate Update on Imaging Division
PR Newswire - Wed Apr 22, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge photonics technologies. The Company was founded with the vision to grow shareholder value by commercializing photonic technologies that offer both superior performance and economic advantages over competing technologies. Recent developments in the imaging industry have brought the Company closer to realizing this vision with respect to its patented LFs scintillation crystals, solid-state MAPD photo detectors and associated imaging technologies.
ZMS.VN: 0.400 (-0.005)
Global Nuclear Imaging Market 2015-2019: Key Vendors are GE healthcare, Philips Healthcare & Siemens Healthcare
M2 - Mon Mar 30, 2:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b7j6qv/global_nuclear) has announced the addition of the "Global Nuclear Imaging Market 2015-2019" report to their offering. The analysts forecast the Global Nuclear Imaging market to grow at a CAGR of 5.89 percent over the period 2014-2019. The report, Global Nuclear Imaging market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Nuclear Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. One of the emerging trends in the market is the rise in the use of positron emission tomography scans. PET scans are more accurate in detecting and locating cancerous tissues and also helpful in evaluating and staging recurrent diseases. According to the report, the market is predominantly driven by the increased use of nuclear medicine for detecting diseases at an early stage. Many cardiac diseases and cancers in the early stages can be diagnosed with the help of nuclear imaging. Rise in the incidences of cancer also contributes to the growth of the market. Further, the report states that the growth of the market is inhibited by certain serious challenges such as the shortage of radioisotopes. According to the World Nuclear Association, approximately 40-45 million nuclear medicine procedures are performed each year. The Global Nuclear Imaging market can be segmented into the revenue generated from the following segment such as SPECT and PET. Key Vendors - GE healthcare - Philips Healthcare - Siemens Healthcare Other Prominent Vendors - Brain Biosciences - CardiArc - CMR Naviscan - DDD-Diagnostic - Digirad - FMI Medical Systems - GVI Medical Devices - Intramedical Imaging - Mediso Medical Imaging Systems - Neurologica - Neusoft Medical Systems - NIPK Electron - NuCare Medical Systems - ONCOVISION - Photo Diagnostic System - Shimadzu - SurgicEye GmbH - Synchropet - Toshiba America Medical Systems - Zecotek Photonics For more information visit http://www.researchandmarkets.com/research/b7...al_nuclear
MDSY: 1.62 (-0.18)
SeeThruEquity Initiates Coverage on Zecotek Photonics Inc. (TSXV: ZMS) with Price Target of $1.78
ACCESSWIRE - Thu Feb 05, 8:01AM CST
NEW YORK, NY / ACCESSWIRE / February 5, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has initiated coverage of Zecotek Photonics Inc. (TSXV: ZMS) with a Price Target of $1.78.
MDSY: 1.62 (-0.18), ZMS.VN: 0.400 (-0.005)
Zecotek Announces Breakthrough Manufacturing Technology for Metal Powders used with 3D Printers
PR Newswire - Mon Feb 02, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced thatits wholly owned subsidiary Zecotek Display Systems Pte. Ltd. and its strategic partners the Institute of Chemical Physics and LT-Pyrkal have successfully developed a unique manufacturing technology for metal powders to be used with 3D printers. The new manufacturing approach uses metal hydrides synthesis and has significant advantages over traditional techniques: high productivity, superior quality ofsynthesizedhydride, significantly lower energy consumption, ecological purity and safety of the process among other keyfunctional parameters.
ZMS.VN: 0.400 (-0.005)
Zecotek Receives US$2.5 million Payment for LFS Scintillation Crystals Purchase Orders
CNW Group - Mon Dec 29, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that its subsidiary Zecotek Imaging Systems Pte. Ltd. has received a payment of US $2.5 million for new and previous orders of the Company`s patented LFS crystals and crystal arrays. The total sum includes an initial payment of US$500,000, as part of a long term plan to supply crystal arrays for use in new generation Time of Flight positron emission tomography (PET) scanners, and pre-clinical scanners for pharmaceutical drug development.
ZMS.VN: 0.400 (-0.005)
IIROC Trading Resumption - ZMS
CNW Group - Tue Dec 23, 12:27PM CST
Trading resumes in:
ZMS.VN: 0.400 (-0.005)
IIROC Trade Resumption - Zecotek Photonics Inc.
Newsfile Corp - Tue Dec 23, 12:20PM CST
Trading resumes in:
Zecotek Settles Lawsuit Against Philips and Saint Gobain
CNW Group - Tue Dec 23, 12:14PM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that its subsidiary, Zecotek Imaging Systems Pte. Ltd., has settled its lawsuit against Philips and Saint Gobain, as parties in a legal proceeding started in February 2012 in connection with an alleged infringement of Zecotek`s patents on LFS scintillation crystals used in positron emission tomography (PET) imaging systems.
ZMS.VN: 0.400 (-0.005)
Zecotek Granted Patent from Japanese Patent Office for its 3D Display Technology
CNW Group - Wed Jul 08, 8:57AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Japanese Patent Office has issued a patent to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 and U.S. patent number 9,055,288 granted in June 2015 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.400 (-0.005)
Zecotek Provides Corporate Update on 3D Technology Division
CNW Group - Mon Jul 06, 5:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge 3D display and 3D printing technologies. The Company was founded with a vision to grow shareholder value by commercializing photonic technologies that offer both superior performance and economic advantages over competing technologies. Zecotek`s internationally patented 3D auto-stereoscopic, full high definition display monitor and patent pending 3D metal printer provide substantial business opportunities for the robust and inevitable future markets based on 3D technologies.
ZMS.VN: 0.400 (-0.005)
CERN Tests Show Zecotek's Patented LFS Scintillation Crystals Achieve Superior Coincident Timing Resolution for New High Performance PET Scanners
CNW Group - Tue Jun 16, 7:45AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I;OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Company's patented LFS scintillation crystals achieved a more precise coincident time resolution (CTR) when compared to competing crystals in tests conducted by a CERN research group, on crystals with dimensions used in commercial positron emission tomography (PET) medical scanners. The results were presented at a recent 2015 IEEE Nuclear Science Conference in Seattle and have been published in major journals.(i)
ZMS.VN: 0.400 (-0.005)
Zecotek Granted U.S. Patent for Switchable 3D/2D Optical Imaging System
PR Newswire - Mon Jun 01, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has granted U.S. Patent No. 9,055,288 to Zecotek for technology related to the Company's switchable 3D/2D optical imaging system. This patent adds to the global portfolio of patents, including U.S. patent number 7,944,465 covering Zecotek's glasses-free 3D auto-stereoscopic display system.
ZMS.VN: 0.400 (-0.005)
Zecotek Provides Corporate Update on Imaging Division
PR Newswire - Wed Apr 22, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge photonics technologies. The Company was founded with the vision to grow shareholder value by commercializing photonic technologies that offer both superior performance and economic advantages over competing technologies. Recent developments in the imaging industry have brought the Company closer to realizing this vision with respect to its patented LFs scintillation crystals, solid-state MAPD photo detectors and associated imaging technologies.
ZMS.VN: 0.400 (-0.005)
Global Nuclear Imaging Market 2015-2019: Key Vendors are GE healthcare, Philips Healthcare & Siemens Healthcare
M2 - Mon Mar 30, 2:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b7j6qv/global_nuclear) has announced the addition of the "Global Nuclear Imaging Market 2015-2019" report to their offering. The analysts forecast the Global Nuclear Imaging market to grow at a CAGR of 5.89 percent over the period 2014-2019. The report, Global Nuclear Imaging market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Nuclear Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. One of the emerging trends in the market is the rise in the use of positron emission tomography scans. PET scans are more accurate in detecting and locating cancerous tissues and also helpful in evaluating and staging recurrent diseases. According to the report, the market is predominantly driven by the increased use of nuclear medicine for detecting diseases at an early stage. Many cardiac diseases and cancers in the early stages can be diagnosed with the help of nuclear imaging. Rise in the incidences of cancer also contributes to the growth of the market. Further, the report states that the growth of the market is inhibited by certain serious challenges such as the shortage of radioisotopes. According to the World Nuclear Association, approximately 40-45 million nuclear medicine procedures are performed each year. The Global Nuclear Imaging market can be segmented into the revenue generated from the following segment such as SPECT and PET. Key Vendors - GE healthcare - Philips Healthcare - Siemens Healthcare Other Prominent Vendors - Brain Biosciences - CardiArc - CMR Naviscan - DDD-Diagnostic - Digirad - FMI Medical Systems - GVI Medical Devices - Intramedical Imaging - Mediso Medical Imaging Systems - Neurologica - Neusoft Medical Systems - NIPK Electron - NuCare Medical Systems - ONCOVISION - Photo Diagnostic System - Shimadzu - SurgicEye GmbH - Synchropet - Toshiba America Medical Systems - Zecotek Photonics For more information visit http://www.researchandmarkets.com/research/b7...al_nuclear
MDSY: 1.62 (-0.18)
SeeThruEquity Initiates Coverage on Zecotek Photonics Inc. (TSXV: ZMS) with Price Target of $1.78
ACCESSWIRE - Thu Feb 05, 8:01AM CST
NEW YORK, NY / ACCESSWIRE / February 5, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has initiated coverage of Zecotek Photonics Inc. (TSXV: ZMS) with a Price Target of $1.78.
MDSY: 1.62 (-0.18), ZMS.VN: 0.400 (-0.005)
Zecotek Announces Breakthrough Manufacturing Technology for Metal Powders used with 3D Printers
PR Newswire - Mon Feb 02, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced thatits wholly owned subsidiary Zecotek Display Systems Pte. Ltd. and its strategic partners the Institute of Chemical Physics and LT-Pyrkal have successfully developed a unique manufacturing technology for metal powders to be used with 3D printers. The new manufacturing approach uses metal hydrides synthesis and has significant advantages over traditional techniques: high productivity, superior quality ofsynthesizedhydride, significantly lower energy consumption, ecological purity and safety of the process among other keyfunctional parameters.
ZMS.VN: 0.400 (-0.005)
Zecotek Receives US$2.5 million Payment for LFS Scintillation Crystals Purchase Orders
CNW Group - Mon Dec 29, 8:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that its subsidiary Zecotek Imaging Systems Pte. Ltd. has received a payment of US $2.5 million for new and previous orders of the Company`s patented LFS crystals and crystal arrays. The total sum includes an initial payment of US$500,000, as part of a long term plan to supply crystal arrays for use in new generation Time of Flight positron emission tomography (PET) scanners, and pre-clinical scanners for pharmaceutical drug development.
ZMS.VN: 0.400 (-0.005)
IIROC Trading Resumption - ZMS
CNW Group - Tue Dec 23, 12:27PM CST
Trading resumes in:
ZMS.VN: 0.400 (-0.005)
IIROC Trade Resumption - Zecotek Photonics Inc.
Newsfile Corp - Tue Dec 23, 12:20PM CST
Trading resumes in:
Zecotek Settles Lawsuit Against Philips and Saint Gobain
CNW Group - Tue Dec 23, 12:14PM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that its subsidiary, Zecotek Imaging Systems Pte. Ltd., has settled its lawsuit against Philips and Saint Gobain, as parties in a legal proceeding started in February 2012 in connection with an alleged infringement of Zecotek`s patents on LFS scintillation crystals used in positron emission tomography (PET) imaging systems.
ZMS.VN: 0.400 (-0.005)
